This is a follow-up to a recent post on why I think direct-to-consumer advertising of prescription drugs is wrong. This post is going to look specifically at marketing by drug companies aimed at health care professionals. Primarily this relationship between Big Pharma and psychiatry involves targeting physicians, since they're doing the majority of the prescribing. … Continue reading Big Pharma and Psychiatry – Necessary Evil or Tango with the Devil?
In many countries, direct to consumer advertising (DTCA) of prescription drugs is either prohibited or tightly restricted. The United States is a notable exception, along with New Zealand. For tv ads, the standard pattern is to talk about the illness, talk about the amazing benefits of the drug, and then provide the required long list … Continue reading Should Direct-to-Consumer Advertising of Rx Drugs Be Banned?
I recently saw an article on the Canadian news site cbc.ca. It warned that there was a manufacturer's shortage of the antidepressant bupropion, both brand name and generic. No reason was given for the shortage, and Health Canada doesn't require this information. The brand name manufacturer told CBC that the shortage had been resolved … Continue reading Manufacturer’s Shortage – Where Did Our Meds Go?